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ing polar fats and cholesterol to move through the water inside and outside cells (3) . These lipoproteins are classified into five main types depending on their density and include low-density lipoproteins (LDLs) and high-density lipoproteins (HDLs), commonly referred to as "bad" and "good" cholesterol, respectively.
Maintaining physiologically healthy level of cholesterol (cholesterol homeostasis) is a complex processes involving multiple factors (10) . The metabolism of lipoproteins plays a central role here since lipoproteins mediate the transport of cholesterol to and from tissues (6) . Other factors include the intake of dietary cholesterol (ϳ2-3 g/day), regulated cholesterol de novo synthesis (ϳ1 g/day), and controlled cholesterol usage, recycling, and excretion (1, 21) . On the other hand, abnormalities in cholesterol serum levels lead to health problems. In particular, prevalent in Western countries are cardiovascular problems associated with high blood LDL levels and lowered HDL levels. In fact, a high blood cholesterol level has been identified as a classic coronary risk factor. It is suspected to cause one-third of coronary heart diseases, which cause up to 2.6 million deaths each year (according to the World Health Organization). Leading a healthy lifestyle focused on a lowcholesterol high-fiber diet and physical activity is advocated to prevent elevated blood cholesterol, whereas statins (cholesterol de novo synthesis inhibitors) are the most widely prescribed class of drugs for lowering high blood cholesterol (12, 22) . Although much is already known about cholesterol circulatory transport and de novo synthesis, the exact mechanism responsible for cholesterol homeostasis and its disturbance remain not fully understood and even ambiguous (11, 24) .
Obtaining detailed knowledge of human cholesterol homeostasis and the development of cardiovascular diseases is limited, due to ethical restrictions, to research centered on animal feeding studies, epidemiological surveys, or clinical trials (16, 18) . The majority of controlled studies can be performed on animals, but species-to-species variability in the plasma cholesterol response to dietary cholesterol as well as the distinctly different plasma lipoprotein profiles of most animal models make the clinical applicability of the obtained findings complicated. Mathematical modeling of cholesterol homeostasis can help in gaining further understanding of the problem and facilitate the selection of the optimal preventive measures and treatment methods. To our knowledge, not much has been done in this area. A few attempts to model cholesterol transport were made in the 1970s, along with studies assessing the long-term turnover of plasma cholesterol examined by injecting intravenously isotopically labeled cholesterol (13) . The previous work included models of lipoprotein dynamics, e.g., a model of the fluid dynamics of lipid accumulation on the arterial walls (14) and chemical kinetics of LDL oxidation (5), as well as a model of lipoprotein metabolism (2) . Building on that, we have previously developed a two-compartment mathematical model to investigate cholesterol circulatory transport and de novo synthesis in the liver and showed its applicability to investigate the processes associated with high blood cholesterol diagnosis and treatment (15) . As students often have problems with understanding the key players and their relationship in maintaining cholesterol homeostasis, we prepared a step-by-step algorithm to use the model and prepared three interactive exercises to facilitate students' learning experiences. Here, we demonstrate the teaching aspects of our model for the complex mechanisms of cholesterol homeostasis aimed toward undergraduate medical students or those in related fields.
METHODS

Two-Compartment Mathematical Model of Cholesterol Homeostasis
Details on the development of the model can be found in Ref. 15 . Briefly, we have reviewed cholesterol homeostasis-related publications and gathered textbook knowledge to outline the key pathways of human cholesterol circulatory transport and de novo synthesis (Fig. 1) . We distinguished the following six main stages.
First, exogenous cholesterol enters the gastrointestinal tract during meals with foods containing animal cholesterol-rich products (Fig. 1,  pathway 1) , and, upon reaching the small intestine, it is absorbed into the lymphatic system in the form of chylomicrons. These gradually release fatty acids (energy source) and form remnants, which enter the bloodstream and are taken up by the liver via specific receptors (pathway 2).
Second, bile circulates between the intestine and liver (pathways 3 and 4). Bile released from the liver contains up to 8% cholesterol, whereas bile returning to the liver via the portal vein contains an additional amount of cholesterol derived from membranes of dead cells of the intestinal epithelium (up to 500 mg cholesterol/day). An additional factor linking bile and cholesterol is cholic acid, which constitutes Ͼ60% of bile and is partially synthesized in the liver from cholesterol.
Third, the liver is the main place of de novo cholesterol synthesis (pathway 5). The synthesis rate depends on the amount of cholesterol already present in the liver: in principle, the lower amount of cholesterol, the higher the de novo synthesis rate and vice versa.
Fourth, cholesterol is released from the liver into the bloodstream in the form of very-low-density lipoproteins, which are transformed to intermediate-density lipoproteins (pathway 6) and subsequently to LDLs (pathways 7 and 7=). LDLs are captured by specific cellular receptors (pathway 8). LDLs are commonly referred to as bad cholesterol as the development of arteriosclerosis (thickening and hardening of the walls of arteries, hindering blood flow) has been linked with the occurrence of oxidized forms of LDLs. Oxidized cholesterol is accumulated in macrophages (pathway 9), which are gradually converted into foam cells building up atherosclerotic lesions.
Fifth, the reverse cholesterol transport, back from the peripheral tissues to the liver, is based on apolipoprotein A 1 , which is synthesized in the liver. With the help of macrophages, apolipoprotein A 1 is enriched in redundant cholesterol in the body. Lipoproteins involved include pre-␤ 1 -HDLs, pre-␤ 2 -HDLs, HDL3s, and HDL2s.
Finally, cholesteryl ester transfer protein facilitates the exchange of cholesterol ester between the lipoproteins (pathway 18).
These six stages were translated into a two-compartment model, where the first compartment represents blood flowing through the liver and the second compartment reflects blood in the peripheral tissues (Fig. 2 ). The model is described by a set of two ordinary differential equations expressing the rate of changes of the cholesterol mass in the two compartments, respectively (Eqs. 1 and 2).
The amount of cholesterol in the first compartment is dependent on de novo cholesterol synthesis with a k rate (inversely proportional to m 1 ), on the rate of exchange between the two compartments (with k 12 and k 21 rates), and on portal circulation represented by m in and m out (the value of m in also captures the amount of cholesterol derived from dead enterocytes). The amount of cholesterol in the second compartment is dependent on the rate of exchange with the first compartment, on the uptake of cholesterol by tissues for structural and functional components (e.g., membrane composition, steroid hormones, and vitamin D synthesis; m tis ), and on the amount of cholesterol obta- ined from diet (m diet ). The values of the model parameters were assigned based on those reported in textbooks and earlier publications (Table 1 ) (15) . The value of k 12 was normalized to 1, and the value of parameter k 21 was chosen so that the total concentration of cholesterol in the peripheral blood did not exceed physiological healthy total cholesterol levels of 200 mg/dl.
Computational Implementation
The set of ordinary differential equations defying the model was implemented in Matlab version 2007b, a high-level technical computing language and environment, and numerically solved using the RungeKutta method (ode45 solver). Two Matlab files (.m) are required for running the simulations: the "equations.m" script specifies the model and "RUN_model_cholesterol_2C.m" is an executable file allowing question-based interactive selection of model parameters values and observing cholesterol changes in the two compartments over the specified time. In addition, we implemented the model in R, a free programming language and software environment for statistical computing and graphics using the deSolve package ("cholesterol.R").
RESULTS
Organization of Content
The computational practical is designed to accompany a physiology module including the subject of cholesterol homeostasis, cholesterol circulatory transport, and/or association between cholesterol and development of cardiovascular diseases. During the lecture or series of lectures covering any of the above topics, the importance of mathematical modeling in biology is explained and the two-compartment mathematical model of cholesterol homeostasis as developed by us (15) is introduced. In the subsequent computer-based practical classes, students run simulations of the cholesterol changes in the physiological and clinical context. Students begin classes with familiarizing themselves with the Matlab/R environment and running the model using the question-based Matlab or script R version implementation of the model. Once comfortable with running the model, students work on three main tasks with increasing difficulty including 1) the assessment of blood cholesterol levels over a range of physiological conditions; 2) simulating high blood cholesterol due to impaired cholesterol uptake by tissues and treatment with de novo cholesterol synthesis inhibitors, including a weekly discontinuation of therapy; and 3) finding individual applications of the model for showing disturbances of blood cholesterol levels and their treatment ( Table 2 ). For this, students require access to computers with installed Matlab or R software as well as the corresponding files defining the model as downloadable from http://biomodel.pwr.wroc.pl/cholesterol-homeostasis/ or available from the Supplemental Material. Step-by-Step Algorithm
To facilitate using the model and running the simulation, we explain a step-by-step algorithm (Fig. 3) . To solve the model, students start with setting the time interval they wish to observe the changes in blood cholesterol (e.g., during a month). In the second step, initial values of cholesterol mass in the liver (compartment I) and bloodstream (compartment II) are set. Subsequently, the values of the model parameters are chosen. These can be either left as the default values (Table 1) or modified given the modeled process of interest, e.g., one can lower the k value to model reduced de novo cholesterol synthesis in the liver. Changes in cholesterol levels in the two compartments, given the specified time interval, initial conditions, and parameter values can now be found by numerically solving the two ordinary differential equations using the Runge-Kutta method. The whole processes can be repeated multiple times by specifying a new time interval, initial conditions, and model parameters values. The results of the changes of cholesterol levels can be presented on a graph. 1 Supplemental Material for this article is available at the Advances in Physiology Education website. Table 1 for definitions of the model parameters. 
Interactive Tasks
Interactive task 1: monitoring blood cholesterol levels over a range of physiological conditions. After familiarizing themselves with running the simulations, students are asked to generate steady-state solutions using the default values of parameters as shown and assuming no dietary cholesterol intake, that is, m diet ϭ 0. The proper solution yields blood cholesterol values (C 2 ) oscillating (due to numeric solutions) around 200 mg/dl. Cholesterol concentration values instead of mass are used to be able to compare the results with standard laboratory practices and cholesterol levels guidelines (e.g., C 2 ϭ m 2 /V 2 , where V 2 is the peripheral blood volume). Now, students are asked to experiment with the values of the model parameters and observe the changes in blood cholesterol levels.
For instance, responses to 10% or 20% increase and decrease changes in the model parameters m out and k can be observed (Fig. 4, A and B) . Students can compare effects of the different parameters values on blood cholesterol levels and discuss which pathway disturbances have the largest influence on cholesterol homeostasis.
Interactive task 2: treating high blood cholesterol levels with de novo cholesterol inhibitors. In the second task, students simulate an elevated blood cholesterol level and its treatment as well as weekly discontinuation of the treatment. Overall, students make three iterations through the algorithm, solving the differential equations for the three cases (raising the blood cholesterol level, treatment, and treatment discontinuation; Fig. 4C ).
High blood cholesterol levels can be caused, for instance, by a diet rich in animal products or by less prevalent genetic disorders affecting the LDL receptor in tissues (familial hypercholesterolemia). Given our model, students can simulate such blood cholesterol level increases by reducing values of m tis , the parameter responsible for cholesterol uptake by peripheral tissues and muscles. Assuming 2-mo of disturbed cholesterol uptake, students can observe an increase of C 2 up to 275 mg/dl. A full set of parameters for this run includes the following: initial values of m 1 ϭ 2,400, m 2 ϭ 8,600, k 12 ϭ 3.5, k 21 ϭ 1, k ϭ 1,500, m in ϭ 1, m out ϭ 1.4, m tis ϭ 0.0351, and m diet ϭ 0 and the 2-mo interval expressed in minutes (t 0 ϭ 0, t 1 ϭ 86,400). Second, students model the treatment of the elevated blood cholesterol level with statins, a class of drugs used to lower cholesterol levels by inhibiting the enzyme 3-hydroxy-3-methylglutaryl-CoA reductase, which plays a central role in the production of cholesterol in the liver. This can be directly simulated by lowering the values of k de novo cholesterol synthesis, e.g., by 30%, and by administrating treatment over a month. Students change the parameter values to m 1 ϭ 3,379, m 2 ϭ 11,828 (as obtained at the end of the 2-mo increasing blood cholesterol period), k 12 ϭ 3.5, k 21 ϭ 1, k ϭ 1,050, m in ϭ 1, m out ϭ 1.4, m tis ϭ 0.0351, and m diet ϭ 0 as well as the 2-mo interval expressed in minutes (t 0 ϭ 86,400, t 1 ϭ 129,600) . Finally, to observe the changes in blood cholesterol during a weekly discontinua- Fig. 3 .
Step-by-step algorithm for running simulations of the cholesterol changes using the two-compartment cholesterol homeostasis model. tion of the treatment, students change the parameters back to the first set, adjust the initial values of cholesterol mass as obtained at the end of the 1-mo treatment (m 1 ϭ 2,645 and m 2 ϭ 9,258), and set a weekly time interval (t 0 ϭ 129,600, t 1 ϭ 139,680). The changes of blood cholesterol over the three periods (2-mo blood cholesterol increase, 1-mo treatment, and 1-wk treatment discontinuation) can be shown on one graph (Fig. 4C) . Interactive task 3: further disturbing and treating cholesterol homeostasis. The model offers ample possibilities for observing changes in blood and liver cholesterol levels under a wide range of physiological conditions, simulated by varying values of model parameters. To ensure students have an active understanding of the modeled cholesterol homeostasis processes, the third task requires students to find their own way of cholesterol homeostasis disturbances and countermeasure strategies. For instance, students can simulate other treatments used for lowering high blood cholesterol. In addition to statins, common treatment includes drugs that bind bile to lower the amount of cholesterol returned to the liver via the portal vein and/or changing diet to the one rich in high-fiber products that increase intestinal peristalsis, reducing intestinal cholesterol absorption (both modeled by reducing values of m in ). Another example of improving unbalanced cholesterol homeostasis is by increasing levels of good cholesterol (HDLs) and lowering levels of bad cholesterol (LDLs). Drugs inhibiting cholesteryl ester transfer protein activity, involved in transferring cholesterol esters between different lipoprotein fractions, are currently under clinical trials, and their effect can be modeled by a simultaneous reduction of k 21 values and an increase of k 12 values.
DISCUSSION
Maintaining healthy levels of blood cholesterols have been established as a key to prevent the development of cardiovascular diseases. Nowadays, basic blood tests measure blood cholesterol levels, and it is a common knowledge that preventing high blood cholesterol levels should be centered on healthy and active lifestyles. Despite that, we found that students struggle with learning about cholesterol homeostasis, most likely due to the fact it is an intensely regulated process involving many factors, both at the molecular and tissue level (10, 21) . To this end, we show how a relatively simple two-compartment model of circulatory cholesterol transportation and de novo synthesis can help students to actively learn, understand, and memorize basic mechanisms behind cholesterol homeostasis.
We offered an opportunity to follow the above interactive exercises to first-year biomedical engineering students. During the 90-min computer practical, the majority of students were able to get comfortable with operating the scripts, especially the more user-friendly Matlab version, and were able to complete all three interactive tasks. Students gave positive feedback and confirmed that the hands-on experiments on cholesterol homeostasis were fun and helpful. By allowing a great flexibility in the third task, it was easy to spot and help students with difficulties. The more ambitious students recognized the Interactive task 2 is the simulated increase of blood cholesterol levels by impaired cholesterol uptake by tissues over 2 mo and subsequent monthly treatment with de novo cholesterol synthesis inhibitors and a weekly discontinuation of the treatment (C). limitations of the model and were eager to discuss ways to improve it. For instance, the model in its current state cannot simulate the gallbladder pathway, in which bile and within in cholic acid, containing 8% of cholesterol, is secreted from the liver to the gallbladder for storage. This level of regulation would require adding an additional compartment representing the gallbladder, and we are currently developing such model. However, already in its current state, the model offers a wide range of applications to simulate disturbances of cholesterol homeostasis and treatment of unbalanced cholesterol levels.
The default values of the majority of the model parameters are based on those reported in textbooks, and thus the model can be interpreted in the physiological, nonabstract, context, e.g., k 12 and k 21 can be considered as LDL and HDL fractions, respectively, and their default ratio is equivalent to the recommend optimal healthy HDL-to-LDL ratio of 3.5 to 1.
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